Fate Therapeutics, Inc.
FATE
$1.00
$0.000.00%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -171.52M | -175.88M | -186.26M | -178.23M | -175.72M |
| Total Depreciation and Amortization | 16.03M | 17.47M | 18.96M | 19.03M | 19.17M |
| Total Amortization of Deferred Charges | -- | -- | -- | 0.00 | 0.00 |
| Total Other Non-Cash Items | 43.96M | 43.02M | 46.38M | 31.72M | 26.18M |
| Change in Net Operating Assets | -4.08M | -7.95M | -1.96M | -4.24M | -10.19M |
| Cash from Operations | -115.61M | -123.33M | -122.87M | -131.71M | -140.57M |
| Capital Expenditure | -3.15M | -1.84M | -730.00K | -813.00K | -883.00K |
| Sale of Property, Plant, and Equipment | 122.00K | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 113.57M | 39.42M | 12.95M | 35.57M | 34.98M |
| Cash from Investing | 110.54M | 37.58M | 12.22M | 34.76M | 34.10M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 0.00 | 0.00 | 75.49M | 75.49M | 75.49M |
| Repurchase of Common Stock | -- | -666.00K | -666.00K | -846.00K | -846.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 4.46M | 5.07M | 25.07M | 21.94M | 21.94M |
| Cash from Financing | 4.46M | 4.40M | 99.89M | 96.58M | 96.58M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -618.00K | -81.35M | -10.76M | -375.00K | -9.89M |